SEC Form 4 · accession 0001209191-16-149980
BIOLASE, INC · BIOL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Harold C Flynn Jr.
Officer — President and CEO · Director
Period of report
Nov 8, 2016
Accepted (ET)
Nov 14, 2016 · 7:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811240
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.45 | Nov 8, 2016 | A | 1,000,000 | A | — | Nov 8, 2026 | Common Stock | 1,000,000 | 2,307,903 | D |
| Restricted Stock UnitF2,F3 | — | Nov 8, 2016 | A | 1,000,000 | A | — | — | Common Stock | 1,000,000 | 1,652,500 | D |
Explanation of responses
- F1One-half of the stock options vest on the second anniversary of the grant date, and the remaining one-half vests ratably on a monthly basis over a two-year period commencing one month following the second anniversary of the grant date, subject to the Reporting Person's continued service with the Company through the applicable vesting dates.
- F2Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
- F3The restricted stock units vest based upon specific performance criteria, subject to the Reporting Person's continued service with the Company through the applicable vesting dates.